Increased Oversight Of FDA Coming, Industry Attorney Warns
This article was originally published in The Silver Sheet
Executive Summary
Now that the election is over and Republicans will soon run Congress, expect GOP members to push for FDA reform, a Latham & Watkins partner predicts.